Gastroenterology
Volume 133, Issue 2 , Pages 517-528, August 2007

Induction of Ovalbumin-Specific Tolerance by Oral Administration of Lactococcus lactis Secreting Ovalbumin

  • Inge L. Huibregtse

      Affiliations

    • Center for Experimental and Molecular Medicine, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands
    • I.L. Huibregtse, and V. Snoeck contributed equally to this manuscript.
  • ,
  • Veerle Snoeck

      Affiliations

    • Department for Molecular Biomedical Research, Flanders Interuniversity Institute for Biotechnology, Ghent, Belgium
    • Department of Molecular Biology, Ghent University, Ghent, Belgium
    • I.L. Huibregtse, and V. Snoeck contributed equally to this manuscript.
  • ,
  • An de Creus

      Affiliations

    • Department for Molecular Biomedical Research, Flanders Interuniversity Institute for Biotechnology, Ghent, Belgium
    • Department of Molecular Biology, Ghent University, Ghent, Belgium
  • ,
  • Henri Braat

      Affiliations

    • Center for Experimental and Molecular Medicine, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands
  • ,
  • Ester C. de Jong

      Affiliations

    • Department of Cell Biology and Histology, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands
  • ,
  • Sander J.H. van Deventer

      Affiliations

    • Center for Experimental and Molecular Medicine, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands
  • ,
  • Pieter Rottiers

      Affiliations

    • Department for Molecular Biomedical Research, Flanders Interuniversity Institute for Biotechnology, Ghent, Belgium
    • Department of Molecular Biology, Ghent University, Ghent, Belgium
    • Corresponding Author InformationAddress requests for reprints to: Pieter Rottiers, PhD, Technologiepark 4 B-9052 Zwijnaarde, Ghent, Belgium. fax: (32) 9 2610619.

Received 22 January 2007; accepted 19 April 2007. published online 04 May 2007.

Background & Aims: Obtaining antigen-specific immune suppression is an important goal in developing treatments of autoimmune, inflammatory, and allergic gastrointestinal diseases. Oral tolerance is a powerful means for inducing tolerance to a particular antigen, but implementing this strategy in humans has been difficult. Active delivery of recombinant autoantigens or allergens at the intestinal mucosa by genetically modified Lactococcus lactis (L lactis) provides a novel therapeutic approach for inducing tolerance. Methods: We engineered the food grade bacterium L lactis to secrete ovalbumin (OVA) and evaluated its ability to induce OVA-specific tolerance in OVA T-cell receptor (TCR) transgenic mice (DO11.10). Tolerance induction was assessed by analysis of delayed-type hypersensitivity responses, measurement of cytokines and OVA-specific proliferation, phenotypic analysis, and adoptive transfer experiments. Results: Intragastric administration of OVA-secreting L lactis led to active delivery of OVA at the mucosa and suppression of local and systemic OVA-specific T-cell responses in DO11.10 mice. This suppression was mediated by induction of CD4+CD25 regulatory T cells that function through a transforming growth factor β-dependent mechanism. Restimulation of splenocytes and gut-associated lymph node tissue from these mice resulted in a significant OVA-specific decrease in interferon γ and a significant increase in interleukin-10 production. Furthermore, Foxp3 and CTLA-4 were significantly up-regulated in the CD4+CD25 population. Conclusions: Mucosal antigen delivery by oral administration of genetically engineered L lactis leads to antigen-specific tolerance. This approach can be used to develop effective therapeutics for systemic and intestinal immune-mediated inflammatory diseases.

Abbreviations used in this paper: APC, antigen presenting cell, BM, bone marrow, DC, dendritic cells, DTH, delayed type hypersensitivity, GALT, gut-associated lymphoid tissue, IFN, interferon, IL, interleukin, LL, Lactococcus lactis, LL-OVA, OVA-secreting L lactis, OT, oral tolerance, OVA, ovalbumin, TCR, T-cell receptor, Treg, regulatory T cell

 

 Supported by the Research Fund of Ghent University (GOA, 01G01205).

 No conflict of interest to disclose.

PII: S0016-5085(07)00931-6

doi:10.1053/j.gastro.2007.04.073

Refers to article:

  • Teaching Tolerance With a Probiotic Antigen Delivery System

    Michel H. Maillard, Scott B. Snapper
    Gastroenterology August 2007 (Vol. 133, Issue 2, Pages 706-709)

Gastroenterology
Volume 133, Issue 2 , Pages 517-528, August 2007